Categories: News

PatientIQ Expands Executive Team; John Gerhardt Joins as Chief Technology Officer

CHICAGO, Feb. 15, 2022 /PRNewswire-PRWeb/ — Today, PatientIQ announced John Gerhardt has joined the Company as its new Chief Technology Officer. With more than a decade of experience driving growth for burgeoning technology companies, Gerhardt will oversee PatientIQ’s engineering and data analytics operations.

“In my career, I’ve always been attracted to companies that are developing truly innovative technology,” said Gerhardt. “The PatientIQ platform helps healthcare providers leverage analytics to improve outcomes for patients across the country, and I’m incredibly energized to take part in that mission.”

Prior to PatientIQ, Gerhardt was vice president of engineering for Contactually, a customer relationship management (CRM) technology company, which he led through a successful acquisition by Compass Real Estate. Gerhardt led multiple organizations over his tenure at Compass, including the company’s Technical Infrastructure, Enterprise Technology, and CRM groups. He also prepared, guided, and executed critical engineering tasks related to taking the company public through IPO.    

“John is an exemplary addition to the PatientIQ executive team,” said Matt Gitelis, CEO, PatientIQ. “His experience leading rapidly growing technology teams responsible for deploying highly scalable data analytics infrastructure will be vital for our next stage of growth.”

The PatientIQ platform is a scalable, cloud-based solution that enables healthcare organizations to collect, analyze, and improve patient-reported outcomes. Its proprietary analytics engine helps to track patient trends, predict patient outcomes, inform clinical decision-making, and optimize quality improvement and reporting.

About PatientIQ    
PatientIQ is the healthcare technology partner for practicing data-driven medicine. Its proprietary, cloud-based platform engages patients to automate the collection of patient-reported outcomes and provide real-time outcome analysis. With PatientIQ, providers are empowered to consistently deliver the highest quality care. Partnering with hospitals, health systems, private practices, and industry customers, PatientIQ has demonstrated years of experience and an unparalleled ability to help push the boundaries of medicine. For more, visit http://www.patientiq.io.

Media Contact

Kendall Shadley, PatientIQ, +1 2315572906, kendall.shadley@patientiq.io

 

SOURCE PatientIQ

Staff

Recent Posts

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

2 hours ago

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

2 hours ago

Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting

Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a…

2 hours ago

Changing Healthcare Trajectories With Positive Experiences

DaVita works with others in under-resourced communities to offer individualized health engagements, break down mistrust…

2 hours ago

Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On

PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its…

2 hours ago

SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

Contract Research Organization for the REGAL trial has informed the Company that 72 events have…

2 hours ago